ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Ahead of the study's publication, the data was shared at the 2026 European Society for Medical Oncology Gastrointestinal ...

Freenome, an early cancer detection company developing blood-based screening tests, today announced favorable results from its pivotal clinical validation study assessing the performance of assay and ...

Stool-based screening for colorectal cancer may be sharper in women than in men, and the reason traces back to sex-specific ...

Time for a rear-ality check. Colorectal cancer rates have been rising among adults younger than 50 since the 1990s, a troubling trend that has perplexed scientists. Because of the increase in cases, ...

A host of companies are competing to bring cancer-detecting blood tests to market.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A blood test that accurately detects colon cancer in middle-aged and ...

When David Thau, a lobbyist in Washington, D.C., was 34, he periodically experienced pain in his stomach, irregular bowel movements, blood in his stool and vomiting, and he visited doctors who ...

An investigational blood test for early detection of colorectal cancer (CRC) in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC study, the largest study ...

A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit ...

With colorectal cancer a growing concern among younger people, the American Cancer Society has endorsed two new types of stool tests to encourage people to get screened while also recommending a ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...